Komori
Caulis (153A) · InitiativeRestated

Investment in research and development

First written in FY2024-Q1. 4 of 6 entries say "Restated". Latest entry: FY2026-H1.

6entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2024-Q1 – FY2025-H1AdvancedFY20252024: 220242025: 220252026: 22026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

34 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Research and development expenses for the interim accounting period were ¥8,184 thousand. There were no material changes in the Company's R&D activities during the period.」

    Discloses R&D expenses of ¥8,184 thousand and states that there were no material changes in activities.
  2. FY2025AdvancedAnnual report

    「During the fiscal year, R&D activities continued to analyze devices and users on the internet to improve fraud detection accuracy for cybersecurity purposes. In addition, the Company began investigating and organizing a research platform for validating AML and fraudulent-transfer network analysis.」

    Research into device and user identification and improved fraud detection continued, while work began on an AML and fraudulent-transfer network analysis platform. R&D expenses were ¥32,009 thousand.
  3. FY2025-H1RestatedAnnual report

    「Research and development expenses for the interim accounting period were ¥15,694 thousand. There were no material changes in the Company's R&D activities during the period.」

    Discloses R&D expenses of ¥15,694 thousand and states that there were no material changes in activities.
  4. FY2024RestatedAnnual report

    「During the fiscal year, R&D activities continued to focus on analyzing attributes for individually identifying devices on the internet for cybersecurity purposes, as well as researching countermeasures against increasingly frequent phishing attacks.」

    R&D focused on cybersecurity and phishing countermeasures continued, with R&D expenses of ¥34,440 thousand.
  5. FY2024-H1RestatedAnnual report

    「Research and development expenses for the interim accounting period were ¥17,210 thousand. There were no material changes in the Company's R&D activities during the period.」

    Discloses interim-period R&D expenses of ¥17,210 thousand and states that there were no material changes in R&D activities.
  6. FY2024-Q1First statedAnnual report

    「Research and development expenses for the first-quarter cumulative period were ¥8,922 thousand.」

    Discloses R&D expenses for the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Caulis yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Investment in research and development | Caulis Inc. (153A) | Komori